Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections.

Source:http://linkedlifedata.com/resource/pubmed/id/16048928

Download in:

View as

General Info

PMID
16048928